Chesley Taft & Associates’s Achaogen Inc AKAO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-11,915
| Closed | – | – | 302 |
|
|
2022
Q1 | $0 | Hold |
11,915
| – | – | ﹤0.01% | 311 |
|
|
2021
Q4 | $0 | Hold |
11,915
| – | – | ﹤0.01% | 304 |
|
|
2021
Q3 | $0 | Hold |
11,915
| – | – | ﹤0.01% | 302 |
|
|
2021
Q2 | $0 | Hold |
11,915
| – | – | ﹤0.01% | 294 |
|
|
2021
Q1 | $0 | Hold |
11,915
| – | – | ﹤0.01% | 296 |
|
|
2020
Q4 | $0 | Hold |
11,915
| – | – | ﹤0.01% | 290 |
|
|
2020
Q3 | $0 | Hold |
11,915
| – | – | ﹤0.01% | 270 |
|
|
2020
Q2 | $0 | Hold |
11,915
| – | – | ﹤0.01% | 265 |
|
|
2020
Q1 | $0 | Hold |
11,915
| – | – | ﹤0.01% | 272 |
|
|
2019
Q4 | $0 | Sell |
11,915
-7,900
| -40% | – | ﹤0.01% | 272 |
|
|
2019
Q3 | $0 | Hold |
19,815
| – | – | ﹤0.01% | 274 |
|
|
2019
Q2 | $0 | Hold |
19,815
| – | – | ﹤0.01% | 263 |
|
|
2019
Q1 | $9K | Hold |
19,815
| – | – | ﹤0.01% | 253 |
|
|
2018
Q4 | $24K | Hold |
19,815
| – | – | ﹤0.01% | 251 |
|
|
2018
Q3 | $79K | Hold |
19,815
| – | – | 0.01% | 276 |
|
|
2018
Q2 | $172K | Buy |
19,815
+1,740
| +10% | +$21.2K | 0.01% | 268 |
|
|
2018
Q1 | $234K | Buy |
+18,075
| New | +$205K | 0.02% | 254 |
|
Chesley Taft & Associates's AKAO Position: Q2 2022 in Review
Chesley Taft & Associates sold out of Achaogen Inc (AKAO) in Q2 2022, closing a stake of 11,915 shares.
Chesley Taft & Associates first reported a position in AKAO in Q1 2018 and held it in 17 quarters. The position peaked at $234K in Q1 2018. 1 fund tracked by Wall St. Rank holds AKAO as of Q2 2022.
- Chesley Taft & Associates reported no remaining Achaogen Inc position as of Q2 2022 after selling out during the quarter.
- Chesley Taft & Associates sold 11,915 Achaogen Inc shares in Q2 2022.
- Chesley Taft & Associates first reported a position in Achaogen Inc in Q1 2018 and held it in 17 quarters.
- Chesley Taft & Associates's Achaogen Inc position peaked at $234K in Q1 2018.
- 1 fund tracked by Wall St. Rank held Achaogen Inc as of Q2 2022.
Based on Chesley Taft & Associates's 13F filing for Q2 2022, filed 7 Jul 2022.